glp-1 gip medications side effects muscle loss Do drugs shrink your muscles? New study explains the risks and what to do Tirzepatide vs. Semaglutide: What You
Description
10.1161/CIRCULATIONAHA.122.059595 3
Woo AYH, Xiao R
Large clinical trials have reinforced these recommendations
Among the diverse array of antidiabetic agents, the class of GLP-1 receptor agonists has garnered substantial attention not only for their glycemic control properties but also for their potential cardiovascular benefits (8)
2022 Dec;118(6):11501158
